{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:22:11Z","timestamp":1756902131292,"version":"3.44.0"},"reference-count":21,"publisher":"The Pediatric Pharmacy Association","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"<jats:p>Pediatric septic shock is a life-threatening condition with significant rates of morbidity and mortality. Standard management includes fluid resuscitation, timely antimicrobial administration, and epinephrine or norepinephrine if unresolved with initial management. Additional therapies are not well defined and include vasopressin, hydrocortisone, phenylephrine, levosimendan, dopamine, and others. Many of these agents modify cellular effects of calcium in the smooth muscle. The use of a calcium infusion may improve vasoactivity in the smooth muscle without the use of signaling pathways. Children are more susceptible to the effects of calcium, which may predispose them to enhanced vasoconstriction with the administration of intravenous calcium. We present a case in which a patient on chronic calcium channel blocker therapy presented with septic shock. She continued to remain hypotensive after fluid resuscitation, antibiotics, epinephrine, and norepinephrine. Her blood pressure improved with the initiation of a continuous calcium chloride infusion. Norepinephrine and epinephrine doses were decreased after the initiation of the calcium infusion.<\/jats:p>","DOI":"10.5863\/1551-6776-27.8.765","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T18:21:47Z","timestamp":1668709307000},"page":"765-769","source":"Crossref","is-referenced-by-count":2,"title":["Calcium Responsive Pediatric Septic Shock Refractory to Isotonic Crystalloids and Inotropic Agents"],"prefix":"10.5863","volume":"27","author":[{"given":"Aviva J.","family":"Whelan","sequence":"first","affiliation":[{"name":"Department of Clinical Pediatrics (AJW), OSF Healthcare Children's Hospital of Illinois, Peoria, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Ricci","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine (MR), OSF Healthcare Children's Hospital of Illinois, Peoria, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron A.","family":"Harthan","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy (AAH), OSF Healthcare Children's Hospital of Illinois, Peoria, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish","family":"Deshpande","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine (GD), Department of Pediatrics, University of Illinois College of Medicine at Peoria, OSF Healthcare Children's Hospital of Illinois, Peoria, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"issue":"2","key":"2022111718184469400_i2331-348X-27-8-765-b1","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/PCC.0000000000002198","article-title":"Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"2022111718184469400_i2331-348X-27-8-765-b2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/CCM.0000000000002425","article-title":"American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock","volume":"45","author":"Davis","year":"2017","journal-title":"Crit Care Med"},{"issue":"4","key":"2022111718184469400_i2331-348X-27-8-765-b3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.2018.9071","article-title":"Association between the New York sepsis care mandate and in-hospital mortality for pediatric sepsis","volume":"320","author":"Evans","year":"2018","journal-title":"JAMA"},{"issue":"26","key":"2022111718184469400_i2331-348X-27-8-765-b4","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa1101549","article-title":"Mortality after fluid bolus in African children with severe infection","volume":"364","author":"Maitland","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"2022111718184469400_i2331-348X-27-8-765-b5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clp.2011.12.010","article-title":"Neonatal blood pressure support: the use of inotropes, lusitropes, and other vasopressor agents","volume":"39","author":"Noori","year":"2012","journal-title":"Clin Perinatol"},{"key":"2022111718184469400_i2331-348X-27-8-765-b6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1741-7015-11-68","article-title":"Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial","volume":"11","author":"Maitland","year":"2013","journal-title":"BMC Medicine"},{"issue":"3","key":"2022111718184469400_i2331-348X-27-8-765-b7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s00246-015-1322-2","article-title":"Initial observations of the effects of calcium chloride infusions in pediatric patients with low cardiac output","volume":"37","author":"Averin","year":"2016","journal-title":"Pediatr Cardiol"},{"issue":"11","key":"2022111718184469400_i2331-348X-27-8-765-b8","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1097\/CCM.0b013e31828cf436","article-title":"Calcium supplementation during sepsis exacerbates organ failure and mortality via calcium\/calmodulin-dependent protein kinase kinase signaling","volume":"41","author":"Collage","year":"2013","journal-title":"Crit Care Med"},{"issue":"4","key":"2022111718184469400_i2331-348X-27-8-765-b9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1542\/peds.75.4.737","article-title":"Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia","volume":"75","author":"Epstein","year":"1985","journal-title":"Pediatrics"},{"issue":"4","key":"2022111718184469400_i2331-348X-27-8-765-b10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00006565-198512000-00007","article-title":"An infant fatality following verapamil therapy for supraventricular tachycardia: cardiovascular collapse following intravenous verapamil","volume":"1","author":"Garland","year":"1985","journal-title":"Pediatr Emerg Care"},{"issue":"1","key":"2022111718184469400_i2331-348X-27-8-765-b11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1570161113666151014122557","article-title":"Cellular and molecular mechanisms of low cardiac output syndrome after pediatric cardiac surgery","volume":"14","author":"Bautista-Hernandez","year":"2016","journal-title":"Curr Vasc Pharmacol"},{"issue":"2","key":"2022111718184469400_i2331-348X-27-8-765-b12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0021-9258(19)43072-X","article-title":"Developmental changes in the composition and function of sarcoplasmic reticulum","volume":"149","author":"Boland","year":"1974","journal-title":"J Biol Chem"},{"issue":"7","key":"2022111718184469400_i2331-348X-27-8-765-b13","first-page":"613","article-title":"Maturation of cardiomyocytes derived from human pluripotent stem cells: current strategies and limitations","volume":"41","author":"Jiang","year":"2018","journal-title":"Mol Cells"},{"issue":"6","key":"2022111718184469400_i2331-348X-27-8-765-b14","doi-asserted-by":"crossref","first-page":"H1221","DOI":"10.1152\/ajpheart.00409.2019","article-title":"Increased myocyte calcium sensitivity in end-stage pediatric dilated cardiomyopathy","volume":"317","author":"Nakano","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"2022111718184469400_i2331-348X-27-8-765-b15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/bja\/67.2.178","article-title":"Calcium for resuscitation?","volume":"67","author":"Erdmann","year":"1991","journal-title":"Br J Anaesth"},{"issue":"9","key":"2022111718184469400_i2331-348X-27-8-765-b16","doi-asserted-by":"crossref","first-page":"a004549","DOI":"10.1101\/cshperspect.a004549","article-title":"Calcium signaling in smooth muscle","volume":"3","author":"Hill-Eubanks","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"2022111718184469400_i2331-348X-27-8-765-b17","first-page":"329","article-title":"Correlation between severity of septic conditions and circulating levels of ionized calcium","volume":"15","author":"Vadstrup","year":"1989","journal-title":"Intensive Care Med"},{"issue":"6","key":"2022111718184469400_i2331-348X-27-8-765-b18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/phar.1396","article-title":"Management of extravasation injuries: a focused evaluation of noncytotoxic medications","volume":"34","author":"Reynolds","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"1","key":"2022111718184469400_i2331-348X-27-8-765-b19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00000542-199007000-00010","article-title":"Ionization and hemodynamic effects of calcium chloride and calcium gluconate in the absence of hepatic function","volume":"73","author":"Martin","year":"1990","journal-title":"Anesthesiology"},{"issue":"7618","key":"2022111718184469400_i2331-348X-27-8-765-b20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature19102","article-title":"Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs","volume":"537","author":"Tang","year":"2016","journal-title":"Nature"},{"issue":"suppl A","key":"2022111718184469400_i2331-348X-27-8-765-b21","doi-asserted-by":"crossref","first-page":"A56","DOI":"10.1093\/eurheartj\/18.suppl_A.56","article-title":"Major differences among the three classes of calcium antagonists","volume":"18","author":"Ferrari","year":"1997","journal-title":"Eur Heart J"}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/27\/8\/765\/3147336\/i2331-348x-27-8-765.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/27\/8\/765\/3147336\/i2331-348x-27-8-765.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T18:33:29Z","timestamp":1738780409000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/27\/8\/article-p765.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":21,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,11,17]]},"published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-27.8.765","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"type":"electronic","value":"2331-348X"},{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2022,11,17]]}}}